glp-1 liver toxicity Frontiers Therapeutic Mechanisms and Clinical Effects

In retrospect, the suspicion that GLP-1RAs provoke acute pancreatitis can be traced to the diagnostic criteria used for acute pancreatitis (two out of the following three features: severe upper abdominal pain radiating into the back, elevations in amylase and/or lipase, and typical results of imaging procedures) and that GLP-1RA therapy induces abdominal symptoms in a large number of patients, as well as elevations in amylase and/or lipase

K.GudmundsdottirV.NielsenH

Some providers prescribe metformin as a bridge during GLP-1 discontinuation, particularly for people with insulin resistance or prediabetes

The results prompt safety concerns for GLP-1RAs, especially with high dose administration, regarding gastrointestinal adverse events

2023 [cited 2024 Jul 3]

New study seeks to unlock link between Parkinsons disease, insulin resistance and GLP-1 medications A new study analysing data from Our Future Health volunteers hopes to improve understanding around the causes of Parkinsons disease that could be treated with GLP-1 medications